#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>Effective August 20, 2012
*ExistRefRange>
#ExistRefRangeTable> | Test Number
| Components
| Reference Interval
| | 0080009
| Acetylcholine Receptor Binding Antibody
| Negative: 0.0-0.4 nmol/L Positive: 0.5 nmol/L or greater
| | 0099580
| Acetylcholine Receptor Blocking Antibody
| Negative: 0-15% blocking Indeterminate: 16-24% blocking Positive: 25% or greater blocking
| | 0099521
| Acetylcholine Receptor Modulating Antibody
| Negative: 0-45% modulating Positive: 46% or greater modulating
| | 2005636
| Titin Antibody
| Negative: 0.00 to 0.45 IV Indeterminate: 0.46 to 0.71 IV Positive: 0.72 IV or greater
| | | Striated Muscle Antibody IgG Screen
| Less than 1:40 No antibody detected
| | | Striated Muscle Antibody, IgG Titer
| Less than 1:40 No antibody detected
|
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>In early-onset myasthenia gravis patients with anti-acetylcholine receptor antibodies, the presence of titin antibody indicates a 95-100 percent likelihood of an underlying thymoma.
Refer to Statement B under Testing Information at http://www.aruplab.com. Refer to Statement D under Testing Information at http://www.aruplab.com.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
If Acetylcholine Receptor Binding Antibody result is greater than 0.4 nmol/L or Acetylcholine Receptor Blocking Antibody result is greater than 15 percent, then Acetylcholine Receptor Modulating Antibody will be added. If Striated Muscle Ab is greater than or equal to 1:40, then a titer will be added. Additional charges apply.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
83519; 83516; if reflexed, add 83516 x2; 86255; if reflexed, add 86256
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Myasthenia Gravis, Myasthenia Gravis/Thymoma (Acetylcholine Receptor Antibodies and Striated Muscle |
*ExistCrossReferences>